Two possibilities are plausible as the major mechanisms of the therapeutic role of wholebody hyperthermia (WBH) ; one is an injury to death of tumour cells by WBH stimulation of the chronic insufficient heat dissipation and anaerobic conditions and another a potentiation of immune functions of the host. Based on a marked inhibition by a single trial of WBH of the growth of spontaneous mammary tumours in SHN mice, the above two possibilities were elucidated by this WBH system. Latency, the period between tumour transplantation and the appearance of tumour of palpable size, differed little between mammary tumours transplanted to mice receiving WBH and the same tumours transplanted to the control mice given no WBH. Meanwhile, in mice given no treatment, the latency for tumours from the donor mice which received WBH was significantly longer than that for tumours from the donor mice which given no WBH. These results revealed that the inhibition by a single trial of WBH of mammary tumour growth is ascribed to a direct effect on tumour cells rather than an indirect effect on the host.
Introduction
Whole-body hyperthermia (WBH) is used clinically as a potent therapeutic treatment for cancer.
Tumour cells grow so rapidly that the growth of blood vessels cannot keep up. This results in incomplete heat dissipation by blood flow. Thus, tumour cells are chronically kept at a high temperature with little oxygen, which is enhanced by hyperthermia, and an accumulation of lactic acid is stimulated by an accelerated anaerobic sugar metabolism. This eventually causes the injury and death of tumour cellso.
The stimulation by WBH of the immune function of the organism2)3) would also contribute to its inhibition of the growth of tumour cells.
We previously found that a single trial of WBH with far-infrared rays (FIR) markedly inhibited the growth of spontaneous mammary tumours of mice with few side-effects4)5).
Whether the inhibitory effects of this WBH system are direct, indirect through host, or both was examined in this study.
Materials and Methods

Animals
A high mammary tumour strain of SHN/Mei female mice maintained in our laboratory 6-8) was used.
The characteristics of mammary tumours of this strain were detailed previously7) 8). Throughout the experiments, the animals were kept in plastic cages (18 X 28 X 13 cm) with wood shavings (M size : CLEA JAPAN, Tokyo, Japan), 4-5 per cage, in a windowless animal room, which was air-conditioned (22 and 55-75 % relative humidity) and artificially illuminated (14 hours of light from 0500 to 1900 h), and provided with a commercial diet (Lab MR Breeder : Nihon Nosan Kogyo KK, Yokohama, Japan) and tap water ad libitum.
Whole-body hyperthermia (WBH)
WBH was performed in an insulated room (100 X 190 X 225 cm) lined with steel panels and polyurethane. Room temperature was controlled at 37-42°C by a FIR panel on the ceiling. The distance from the panel to the cages was approximately 1 m. WBH was performed for 3 hours and the body temperature of the mice was maintained at 39-41°C during the procedure.
Transplantation
When a mammary tumour reached 10-15 mm in size, the geometric mean of the major two diameters, the mouse was killed by decapitation under light ether anaesthesia. The tumour was immediately removed, the least necrotic portion was minced with small scissors, and 0.1 ml was packed in a lml disposable syringe and injected subcutaneously at the nape of the neck of each recipient mouse. All procedures were performed under sterile conditions.
Treatments
In Experiment I , minced mammary tumours from 3 donor mice were transplanted to mice receiving no treatment (Control) and mice subjected to WBH for 3 hours 1 hour before (Experimental).
In Experiment II , minced mammary tumours from donor mice given no treatment were transplanted to mice given no treatment (Control) and tumours from donor mice receiving WBH for 3 hours just before transplantation were transplanted to mice receiving no treatment (Experimental). Both the control and the experimental recipients received tumours from different donors.
In both Experiments I and II, 6-11 months-old nulliparous or multiparous mice bearing mammary tumours and 6-8 months-old virgin mice without tumours were used as donors and recipients, respectively.
All mice transplanted with tumours were killed by decapitation under light ether anaesthesia 9 days after tumours became palpable. hyperthermia on mammary tumour growth inhibition.
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Latency period
All mice were gently palpated at the site of transplantation everyday beginning a few days after transplantation and latency was calculated as the period in days between tumour transplantation and the appearance of a tumour of palpable size.
Growth rate of transplanted tumours
Tumour size was expressed in terms of the geometric mean of two major diameters and tumour growth was estimated from the percent change of tumour size during 9 days after tumours became palpable.
Body weight
Recipient mice were weighed right before tumour transplantation and at killing.
Statistics
All values were expressed as the Mean ± SEM. The statistical significance of the difference between the control and the respective experimental groups was evaluated by Student's t-test. As illustrated in Fig. 1 , no difference in the latency period was observed between the control and experimental groups regardless of the tumours transplanted.
Results
Latency periods
On the other hand, in Experiment II , the latency period was significantly elongated in the experimental group compared to the control (Fig. 2 ).
Growth of transplanted tumour
Little difference was observed in the growth of transplanted tumours between the control and experimental groups in either Experiment I or II (data not shown).
The body weight change
In either Experiment I or II, little difference was observed between the control and experimental groups in body weight change at surgery and killing (data not shown).
Discussion
The inhibitory effect of a single trial of WBH on mammary tumours is considered to be both indirect, through the potentiation of immune functions of the host, and direct, affecting the tumour cells themselves'-'). In this study, the latency period of tumours transplanted to mice receiving WBH before The experimental group was transplanted with tumours from donor mice subjected to 3 hours of WBH just before surgery. Both the control and the experimental recipients received tumours from different donor mice. Thus, the numbers of tumours examined are 11 and 9 in the control and the experimental groups, respectively. transplantation differed little from that of the same tumours transplanted to mice given no WBH.
Associated with this, no difference was observed between groups in the weights of thymus and spleen in this study as reported previously44). Meanwhile, the latency period was significantly longer in tumours receiving WBH before transplantation than those given no WBH. Consistent with the present results, the survival of mice transplanted with tumour cells treated with hyperthermia were prolonged compared to those not9).
The observations strongly suggest that WBH affects the mammary tumours directly rather than the host animals at least in the present WBH system (single trial for 3 hours).
Incidentally, the thermal sensitivity of tumours to WBH was increased by pretreatment with glucose4).
The present results, however, do not negate an indirect effect of WBH in the inhibition of mammary tumourigenesis. The marked prevention by WBH of mammary tumour development of SHN mice'°) supports the contribution of WBH to immune reaction in this process.
No difference between the control given no WBH and the experimental group receiving WBH in the tumour growth may mostly be ascribed to the extinction of the inhibitory effects of WBH nearly after tumour mass reached the palpable size.
